繁體
报告查询
报告查询
报告查询
报告查询
报告查询
报告查询
报告查询
报告查询
报告查询
报告查询
报告查询
报告查询
报告查询
报告查询
报告查询
报告查询
报告查询
报告查询
Service
Non-Invasive Prenatal DNA Test
无创产前检查,无创产前检测
Non-Invasive Prenatal screening Test is an innovative genetic test for pregnant women at risk of foetal Patau syndrome (trisomy 13), Edwards’ syndrome (trisomy 18) or Down syndrome (trisomy 21).It can be performed with a single blood sample obtained from the mother from week 10 of pregnancy.Rapid, reliable and safe, NIPT is a screening option that enables detection of trisomies 13, 18 and 21 while limiting the required number of invasive tests (amniocentesis).
Advantages of NIPT
99% 10mL 10 week 7-10day 95%
Detection rate of NIPT Single blood sample x 10mL Available from week 10 of pregnancy Results available within 7-10 business days Can minimize unnecessary invasive sampling by 95%
How does it work?
无创产前检查 Besides maternal DNA, the blood of pregnant women contains foetal DNA originating from the placenta. The identification of this foetal DNA in the maternal blood, combined with the development of a new technology (Next Generation Sequencing) capable of counting all genetic material sequences in a maternal blood sample, makes it possible to determine whether a trisomy is present in the foetus.